Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

The presence of minimal residual disease (MRD) is widely recognized as a powerful predictor of therapeutic outcome in acute myeloid leukemia (AML), but methods of measurement and quantification of MRD in AML are not yet standardized in clinical practice. There is an urgent, unmet need for robust and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Mol Diagn
Main Authors: Mencia-Trinchant, Nuria, Hu, Yang, Alas, Maria Antonina, Ali, Fatima, Wouters, Bas J., Lee, Sangmin, Ritchie, Ellen K., Desai, Pinkal, Guzman, Monica L., Roboz, Gail J., Hassane, Duane C.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Investigative Pathology 2017
Assuntos:
Regular Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500824/
https://ncbi.nlm.nih.gov/pubmed/28525762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2017.03.005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares